Abbvie

Abbvie (ABBV) Inventory Spending Analysis From 2012 To 2016

This report provides the last five years inventory spending analysis of Abbvie Inc. (ABBV) from 2012 to 2016. Abbvie invested a total of $1.4 billion on inventories during 2016. Abbvie generated a total of $25.6 billion revenues during 2016. As a percentage of revenues, Abbvie invested 5.6% of its total revenues on inventories during 2016. The inventory numbers are for the fiscal year ending in December.

Abbvie (ABBV) Cost of Sales (COGS) Analysis From 2012 To 2016

This report provides the last five years cost of sales (COGS) analysis of Abbvie Inc. (ABBV) from 2012 to 2016. Abbvie spent a total of $5.8 billion on COGS during 2016. Abbvie generated a total of $25.6 billion revenues during 2016. As a percentage of revenues, Abbvie spent 22.8% of its total revenues on COGS during 2016. The cost of sales (COGS) numbers are for the fiscal year ending in December.

Abbvie (ABBV) Revenues And Revenue Growth From 2012 To 2016

This report provides the last five years revenues and revenue growth of Abbvie Inc. (ABBV) from 2012 to 2016. Abbvie generated a total of $25.6 billion revenues during 2016. Abbvie reported a revenue growth of 12.2% year-over-year during 2016. The revenues and the revenue growth correspond to the fiscal year ending in December.

Abbvie (ABBV) Net Profit And Net Margin From 2012 To 2016

This report provides the last five years net profit and net margin of Abbvie Inc. (ABBV) from 2012 to 2016. Abbvie reported a total net income of $6 billion during 2016. Abbvie generated a total of $25.6 billion revenues during 2016. Abbvie net profit margin was 23.2% during 2016. The net profit and the net profit margin correspond to the fiscal year ending in December.

Abbvie (ABBV) Business Analysis – Analyze Historical Performance, Strategic Priorities, And Business Improvement Opportunities...

Abbvie Inc. with $26 billion revenues in the year 2016 was the number 2 Biotechnology company. Read this report to know the top competitors of Abbvie and identify growth and cost optimization opportunities of Abbvie

Abbvie (ABBV) Property, Plant & Equipment (PP&E) Investment Analysis From 2012 To 2016

This report provides the last five years property, plant & equipment (PP&E) investment analysis of Abbvie Inc. (ABBV) from 2012 to 2016. Abbvie invested a total of $2.6 billion on property, plant & equipment (PP&E) activities during 2016. Abbvie generated a total of $25.6 billion revenues during 2016. As a percentage of revenues, Abbvie invested 10.2% of its total revenues on PP&E activities during 2016. The PP&E investment numbers are for the fiscal year ending in December.

Abbvie (ABBV) Accounts Receivable (A/R) Analysis From 2012 To 2016

This report provides the last five years Accounts Receivable (A/R) analysis of Abbvie Inc. (ABBV) from 2012 to 2016. Abbvie invested a total of $4.8 billion on accounts receivable during 2016. Abbvie generated a total of $25.6 billion revenues during 2016. As a percentage of revenues, Abbvie invested 18.6% of its total revenues on accounts receivable during 2016. The accounts receivable numbers are for the fiscal year ending in December.

Abbvie (ABBV) Revenues And Revenue Growth From 2009 To 2016

This report provides the last eight years revenues and revenue growth of Abbvie Inc. (ABBV) from 2009 to 2016. Abbvie generated a total of $25.6 billion revenues during 2016. Abbvie reported a revenue growth of 12.2% year-over-year during 2016. The revenues and the revenue growth correspond to the fiscal year ending in December.

Abbvie (ABBV) Net Profit And Net Margin From 2009 To 2016

This report provides the last eight years net profit and net margin of Abbvie Inc. (ABBV) from 2009 to 2016. Abbvie reported a total net income of $6 billion during 2016. Abbvie generated a total of $25.6 billion revenues during 2016. Abbvie net profit margin was 23.2% during 2016. The net profit and the net profit margin correspond to the fiscal year ending in December.

Abbvie (ABBV) Research & Development (R&D) Spending Analysis From 2012 To 2016

This report provides the last five years research and development (R&D) expenses of Abbvie Inc. (ABBV) from 2012 to 2016. Abbvie spent a total of $4.4 billion on research and development (R&D) activities during 2016. Abbvie generated a total of $25.6 billion revenues during 2016. As a percentage of revenues, Abbvie spent 17% of its total revenues on R&D activities during 2016. The R&D spending numbers are for the fiscal year ending in December.